Skip to main content
UniHealth

Doctor search

George A Bertolucci

Ophthalmology · Fresno

NPI 1447267505

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2
Since medical school
40 years
Creighton University School of Medicine, 1986

Offices

2 locations · Fogg Remington Eyecare Inc · Vision Care Center A Medical Group Inc

Looking this up.

Hospitals listed: Fresno Surgical Hospital · Saint Agnes Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call George A Bertolucci’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence G60951 · Current

Licensed to practise in California · since 1987 · expires 2027-08-31 · Creighton University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Surgery centers they own

  • Summit SurgicalAmbulatory Surgery Center · Fresno, CA.9 owner since 2015 · accredited by AAAHC
    Accreditation Renewed1 inspection, 1 with deficiencies · last 2017-05-08: Requirements Met

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Ophthalmology - Ophthalmology

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Fresno Surgical HospitalFresno, CAAcute Care Hospital · Proprietary · No emergency departmentPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 4 of 5 · 84% would definitely recommend it
    No overall ratingBetter than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 1,007 cases, Jan 2024 – Dec 2024
  • Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Fresno Surgical Hospital

Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 1 better, 2 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Fresno Surgical Hospital
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 1,007 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.02 (0 to 2.09) · 413 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.82 (0.35 to 1.28)No differentJul 2022 – Jun 2024
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths4.8 · 439 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.2 (0 to 0.43) · 934 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.25 (0.04 to 0.46) · 918 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.75 (0.56 to 4.94) · 938 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.6 (0 to 3.3) · 929 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.27 (0.67 to 3.88) · 915 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.35 (0 to 13.68) · 929 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths3.95 (0.18 to 7.73) · 899 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.75 (0.22 to 3.28) · 390 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.59 (0 to 1.9) · 238 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 135 casesNoneApr 2023 – Mar 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 129 casesNoneJul 2023 – Jun 2025

What patients said (405 patients answered, 45% of those asked)

Patient survey stars by topic at Fresno Surgical Hospital
Cleanliness4
Nurse communication4
Doctor communication3
Communication about medicines4
Discharge information4
Overall hospital rating4
Quietness4
Recommend hospital5
Share of patients giving the best answer at Fresno Surgical Hospital
Room was "always" clean81%
Nurses "always" communicated well83%
Doctors "always" communicated well80%
Staff "always" explained70%
Yes, staff "did" give patients this information90%
Yes, staff "did" give patients information about help after discharge91%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)82%
Staff "always" explained new medications85%
Nurses "always" explained things so they could understand79%
Nurses "always" listened carefully82%
Nurses "always" treated them with courtesy and respect89%
"Always" quiet at night68%
"YES", patients would definitely recommend the hospital84%
Staff "always" explained possible side effects55%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Saint Agnes Medical Center

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Saint Agnes Medical Center
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.274BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.312BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.141BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.18 to 1.94) · 2,342 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.76 to 1.27)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths197.82 (152.64 to 243.01) · 103 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths3.9 · 105 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.3 · 300 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.9 · 295 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.8 · 768 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.8 · 969 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths11.2 · 304 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.7 · 4,305 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.24 (0.06 to 0.42) · 11,641 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.25 (0.07 to 0.43) · 12,213 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.76 (2.91 to 6.61) · 2,466 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.09 (0 to 2.49) · 864 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.61 (0.26 to 2.96) · 2,362 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.1 (5.39 to 14.81) · 900 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.4 (1.2 to 7.59) · 882 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.84 (0.41 to 3.27) · 541 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.67 (0.14 to 1.19) · 9,626 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.9 · 58 casesNoneApr 2023 – Mar 2025
MRSA BacteremiaInfections0.835No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections1.182No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.004No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 412 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.6 · 1,002 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits28.8 · 296 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits25.5 · 894 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits17.8 · 981 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.1 · 1,061 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5 · 56 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits13.4 · 150 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.3 · 412 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.3 (9.6 to 15.9) · 1,324 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.1) · 863 casesNo differentJan 2024 – Dec 2024

What patients said (812 patients answered, 32% of those asked)

Patient survey stars by topic at Saint Agnes Medical Center
Cleanliness4
Nurse communication3
Doctor communication2
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness3
Recommend hospital4
Share of patients giving the best answer at Saint Agnes Medical Center
Room was "always" clean73%
Nurses "always" communicated well73%
Doctors "always" communicated well74%
Staff "always" explained61%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge83%
Doctors "always" explained things so they could understand70%
Doctors "always" listened carefully73%
Doctors "always" treated them with courtesy and respect80%
Patients who gave a rating of "9" or "10" (high)71%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand68%
Nurses "always" listened carefully70%
Nurses "always" treated them with courtesy and respect80%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital76%
Staff "always" explained possible side effects47%
Yes, staff "did" give patients information about possible symptoms87%

Original Medicare doctor bills

$2,946,995

Medicare paid this office $2,946,995 for 1,439 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, aflibercept, 1 mg138$842,626None
Injection, pegcetacoplan, intravitreal, 1 mg50$558,917None
Injection, faricimab-svoa, 0.1 mg57$476,941None
Injection, ranibizumab, 0.1 mg77$220,884None
Injection of drug into eye401$176,774$86
See all 19 services
Every Original Medicare service billed
Injection, aflibercept, 1 mg138$842,626None
Injection, pegcetacoplan, intravitreal, 1 mg50$558,917None
Injection, faricimab-svoa, 0.1 mg57$476,941None
Injection, ranibizumab, 0.1 mg77$220,884None
Injection of drug into eye401$176,774$86
Injection, aflibercept hd, 1 mg23$169,670None
Unclassified drugs33$107,261None
Imaging of retina1,385$102,967$30
Established patient complete exam of visual system715$66,656$86
Injection, avacincaptad pegol, 0.1 mg11$60,658None
Return visit (30+ min)320$28,600$85
Compounded drug, not otherwise classified103$27,490None
Short return visit (20+ min)265$21,520$61
Established patient problem focused exam of visual system214$19,939$60
Exam of retinal blood vessels using a special camera after injection of a dye44$6,438$126
Removal of recurring cataract in lens capsule using a laser13$3,277$252
New patient visit (45+ min)26$3,007$116
Photography of the retina56$1,617$25
Exam of visual field with extended testing26$1,297$43

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery19More than 43% of doctors who do this

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Injection of drug into eye2,3752,1312,1972,4212,3872,055
Destruction of leaking blood vessels of retina using laser35333730––
Removal of recurring cataract in lens capsule using a laser142430141913
Removal of membrane of retina2317111314–
Injection of drug or substance into membrane covering eyeball1716–13––
Destruction of growth of retina using a laser20–13–––

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

1,439 Original Medicare patients in 2024. Average age 78 · Under 65 4% · 85 and older 24% · Women 59% · Also on Medicaid 14% · Health risk score 1.51. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 75% · Diabetes 42% · Coronary heart disease 42% · Chronic kidney disease 34% · Heart failure 21% · Atrial fibrillation 20% · Cancer 16% · Depression 14% · COPD 11% · Dementia 6% · Stroke 6%.

The office billed $7,086,507, Medicare allowed $3,763,717 and paid $2,946,995; for 34,924 services of 45 kinds; $2,352,878 of it was for drugs given in the office and $594,117 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20241,43934,924781.51$7,086,507$2,946,995
20231,66337,488781.43$9,107,989$3,506,857
20221,86519,456781.40$8,650,875$3,278,680
20211,86417,616781.42$7,915,235$3,144,163
20201,80117,512771.57$7,845,818$3,141,985
20192,00120,758771.54$8,912,371$3,670,022
20182,07222,600771.61$9,672,207$3,818,947
20171,93020,574771.57$8,523,432$3,453,908
20161,64217,712781.51$7,094,488$3,075,731
20151,73418,498781.42$6,669,748$3,317,736
20141,61918,210781.37$6,549,928$3,255,873
20131,41816,604771.35$5,581,318$2,745,622

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 20 services

Original Medicare services billed in 2023
Injection, aflibercept, 1 mg190$1,315,779None
Injection, faricimab-svoa, 0.1 mg64$601,659None
Injection, ranibizumab, 0.1 mg131$539,768None
Unclassified drugs71$231,520None
Injection of drug into eye453$218,112$91
Imaging of retina1,594$129,676$32
Established patient problem focused exam of visual system471$114,863$68
Established patient complete exam of visual system1,035$107,554$91
Injection, pegcetacoplan, intravitreal, 1 mg23$83,049None
Compounded drug, not otherwise classified101$28,683None
Short return visit (20+ min)255$25,886$68
Injection, dexamethasone, intravitreal implant, 0.1 mg11$21,128None
Removal of membrane of retina14$12,956$925
Exam of retinal blood vessels using a special camera after injection of a dye65$7,674$113
Removal of recurring cataract in lens capsule using a laser16$5,387$284
Return visit (30+ min)40$3,977$86
New patient complete exam of visual system25$2,410$96
Photography of the retina70$2,182$28
Exam of visual field with extended testing32$1,795$45
New patient visit (45+ min)14$1,378$98

2022: 23 services

Original Medicare services billed in 2022
Injection, aflibercept, 1 mg194$1,565,857None
Injection, ranibizumab, 0.1 mg159$849,386None
Injection of drug into eye446$214,823$89
Imaging of retina1,778$137,943$32
Established patient problem focused exam of visual system486$126,866$67
Established patient complete exam of visual system1,212$125,030$88
Injection, faricimab-svoa, 0.1 mg17$42,972None
Compounded drug, not otherwise classified116$39,686None
Short return visit (20+ min)233$22,326$64
Exam of retinal blood vessels using a special camera after injection of a dye124$13,879$104
Removal of membrane of retina13$12,089$930
New patient visit (45+ min)85$9,815$115
Removal of eye fluid (vitreous) between lens and retina12$9,424$725
Destruction of leaking blood vessels of retina using laser13$8,168$272
Return visit (30+ min)53$5,244$95
Removal of recurring cataract in lens capsule using a laser13$3,919$280
Photography of the retina121$3,604$28
New patient complete exam of visual system18$2,256$125
Exam of visual field with extended testing30$1,509$47
2d ultrasound scan of eye tissue and structures12$724$40
Injection of drug or substance into membrane covering eyeball13$470$36
Imaging of optic nerve19$426$22
Injection, triamcinolone acetonide, not otherwise specified, 10 mg13$37None

2021: 22 services

Original Medicare services billed in 2021
Injection, aflibercept, 1 mg165$1,392,445None
Injection, ranibizumab, 0.1 mg150$907,353None
Injection of drug into eye420$202,151$92
Established patient complete exam of visual system1,382$154,043$93
Imaging of retina1,772$143,927$33
Established patient problem focused exam of visual system508$126,800$69
Compounded drug, not otherwise classified142$42,224None
Short return visit (20+ min)206$26,097$69
Exam of retinal blood vessels using a special camera after injection of a dye146$15,629$100
Destruction of leaking blood vessels of retina using laser20$10,566$286
Removal of membrane of retina11$10,550$959
Return visit (30+ min)72$7,546$92
New patient visit (45+ min)50$6,653$133
Destruction of growth of retina using a laser13$5,442$419
Photography of the retina147$4,682$30
Removal of recurring cataract in lens capsule using a laser16$4,488$264
Short return visit66$4,334$40
Removal of recurring cataract in lens capsule using a laser13$3,664$282
New patient complete exam of visual system14$1,569$112
Exam of visual field with extended testing26$1,371$49
2d ultrasound scan of eye tissue and structures12$545$42
Imaging of optic nerve21$497$21

2020: 23 services

Original Medicare services billed in 2020
Injection, aflibercept, 1 mg168$1,269,162None
Injection, ranibizumab, 0.1 mg182$1,087,004None
Injection of drug into eye433$175,861$83
Established patient complete exam of visual system1,259$142,180$95
Imaging of retina1,698$136,816$33
Established patient problem focused exam of visual system542$133,055$68
Compounded drug, not otherwise classified127$33,992None
Short return visit (20+ min)193$22,800$59
Injection, brolucizumab-dbll, 1 mg11$18,104None
Removal of membrane of retina17$16,290$958
Exam of retinal blood vessels using a special camera after injection of a dye122$11,747$89
Return visit (30+ min)93$8,334$80
Removal of recurring cataract in lens capsule using a laser24$6,193$258
Photography of the retina136$5,257$36
Destruction of leaking blood vessels of retina using laser11$4,849$285
Destruction of leaking blood vessels of retina using laser12$4,143$259
New patient visit (45+ min)21$2,368$113
New patient complete exam of visual system16$1,819$114
Exam of visual field with extended testing31$1,505$47
Imaging of optic nerve23$847$29
Injection of drug or substance into membrane covering eyeball12$796$50
2d ultrasound scan of eye tissue and structures13$772$45
Injection, triamcinolone acetonide, not otherwise specified, 10 mg12$70None

2019: 24 services

Original Medicare services billed in 2019
Injection, ranibizumab, 0.1 mg219$1,501,096None
Injection, aflibercept, 1 mg152$1,268,898None
Injection of drug into eye450$199,797$84
Established patient complete exam of visual system1,457$168,393$94
Established patient problem focused exam of visual system628$164,537$71
Imaging of retina1,890$157,631$33
Compounded drug, not otherwise classified108$25,512None
Injection, dexamethasone, intravitreal implant, 0.1 mg11$24,044None
Removal of membrane of retina22$21,474$934
Short return visit (20+ min)164$19,201$55
Removal of eye fluid (vitreous) between lens and retina17$12,217$719
Destruction of leaking blood vessels of retina using laser19$9,239$264
Destruction of growth of retina using a laser17$8,749$437
Return visit (30+ min)97$8,070$82
Exam of retinal blood vessels using a special camera after injection of a dye80$6,677$78
Photography of the retina98$4,078$38
Removal of recurring cataract in lens capsule using a laser14$3,484$249
New patient complete exam of visual system24$2,609$109
New patient visit (45+ min)16$1,809$113
Exam of visual field with extended testing29$1,654$52
Injection of drug or substance into membrane covering eyeball13$1,117$66
Imaging of optic nerve24$917$26
2d ultrasound scan of eye tissue and structures13$779$41
Injection, triamcinolone acetonide, not otherwise specified, 10 mg12$81None

2018: 29 services

Original Medicare services billed in 2018
Injection, ranibizumab, 0.1 mg259$1,819,006None
Injection, aflibercept, 1 mg149$1,022,970None
Injection of drug into eye467$209,947$81
Established patient problem focused exam of visual system724$180,247$68
Established patient complete exam of visual system1,450$165,181$92
Imaging of retina1,891$161,983$33
Injection, dexamethasone, intravitreal implant, 0.1 mg12$29,676None
Compounded drug, not otherwise classified119$28,179None
Removal of membrane of retina28$27,908$900
Short return visit (20+ min)203$21,760$53
Removal of membrane of retina with removal of internal limiting membrane of retina19$18,548$927
Destruction of growth of retina using a laser35$17,802$434
Destruction of leaking blood vessels of retina using laser18$15,898$279
Repair of detached retina with drainage and removal of eye fluid between lens and retina12$11,603$893
Removal of eye fluid (vitreous) between lens and retina17$11,395$670
Destruction of eye fluid (vitreous) between lens and retina and all of retina using a laser11$9,487$862
Return visit (30+ min)90$7,473$80
Exam of retinal blood vessels using a special camera after injection of a dye85$6,879$71
Removal of recurring cataract in lens capsule using a laser21$5,914$257
Photography of the retina103$4,946$42
New patient visit (45+ min)43$4,653$108
New patient complete exam of visual system47$4,638$99
Destruction of growth of retina using a laser11$4,320$393
Exam of visual field with extended testing29$1,491$51
Injection of drug or substance into membrane covering eyeball15$1,427$79
Imaging of optic nerve36$1,198$27
2d ultrasound scan of eye tissue and structures14$1,149$60
Injection, bevacizumab, 10 mg14$800None
Injection, triamcinolone acetonide, not otherwise specified, 10 mg15$102None

2017: 25 services

Original Medicare services billed in 2017
Injection, aflibercept, 1 mg174$1,358,472None
Injection, ranibizumab, 0.1 mg197$1,227,694None
Injection of drug into eye451$178,851$81
Established patient problem focused exam of visual system648$163,907$65
Established patient complete exam of visual system1,401$157,218$89
Imaging of retina1,666$139,093$32
Removal of membrane of retina31$29,085$938
Injection, dexamethasone, intravitreal implant, 0.1 mg14$27,685None
Destruction of growth of retina using a laser42$21,508$430
Compounded drug, not otherwise classified110$17,910None
Short return visit (20+ min)146$17,345$54
Removal of membrane of retina with removal of internal limiting membrane of retina11$10,022$835
Removal of eye fluid (vitreous) between lens and retina13$8,931$687
Photography of the retina131$7,505$52
Removal of recurring cataract in lens capsule using a laser29$7,201$240
Exam of retinal blood vessels using a special camera after injection of a dye85$5,969$65
Destruction of leaking blood vessels of retina using laser12$5,357$282
New patient visit (45+ min)41$4,778$117
New patient complete exam of visual system37$4,283$116
Injection, triamcinolone acetonide, preservative free, 1 mg12$2,981None
Return visit (30+ min)31$2,572$83
Exam of visual field with extended testing38$1,945$49
Imaging of optic nerve37$1,411$28
Injection of drug or substance into membrane covering eyeball11$861$78
Injection, triamcinolone acetonide, not otherwise specified, 10 mg11$63None

2016: 19 services

Original Medicare services billed in 2016
Injection, ranibizumab, 0.1 mg219$1,531,182None
Injection, aflibercept, 1 mg97$781,575None
Established patient problem focused exam of visual system633$167,184$66
Injection of drug into eye356$156,525$82
Established patient complete exam of visual system1,209$140,404$90
Imaging of retina1,384$132,789$36
Destruction of growth of retina using a laser64$32,381$421
Injection, dexamethasone, intravitreal implant, 0.1 mg16$25,523None
Removal of membrane of retina21$20,766$944
Compounded drug, not otherwise classified59$10,509None
Removal of eye fluid (vitreous) between lens and retina13$9,566$736
Removal of recurring cataract in lens capsule using a laser28$7,836$261
New patient complete exam of visual system55$6,177$112
Destruction of leaking blood vessels of retina using laser13$5,929$282
Exam of retinal blood vessels using a special camera after injection of a dye49$5,749$90
Photography of the retina83$5,237$60
Exam of visual field with extended testing37$2,006$51
Imaging of optic nerve41$1,855$34
Injection, triamcinolone acetonide, preservative free, 1 mg13$1,745None

2015: 19 services

Original Medicare services billed in 2015
Injection, ranibizumab, 0.1 mg247$1,735,142None
Injection, aflibercept, 1 mg106$802,502None
Established patient problem focused exam of visual system718$183,019$67
Injection of drug into eye402$167,237$82
Imaging of retina1,450$140,304$36
Established patient complete exam of visual system1,180$131,886$90
Destruction of leaking blood vessels of retina using laser22$22,078$818
Removal of membrane of retina21$19,460$927
New patient complete exam of visual system93$9,511$102
Removal of recurring cataract in lens capsule using a laser33$8,330$252
Unclassified biologics58$7,970None
Exam of retinal blood vessels using a special camera after injection of a dye57$7,814$89
Photocoagulation treatment to prevent detachment of retina14$6,466$431
Photography of the retina35$2,359$64
Compounded Drug, Not Otherwise Classified26$2,292$55
Short return visit (20+ min)37$1,514$34
Exam of visual field with extended testing23$1,128$47
Imaging of optic nerve26$1,085$36
Injection, triamcinolone acetonide, preservative free, 1 mg13$1,060None

2014: 20 services

Original Medicare services billed in 2014
Injection, ranibizumab, 0.1 mg277$2,029,120None
Injection, aflibercept, 1 mg67$444,437None
Established patient problem focused exam of visual system623$172,415$68
Injection of drug into eye379$170,739$84
Established patient complete exam of visual system1,148$136,085$91
Imaging of retina1,322$134,887$37
Removal of membrane of retina26$30,980$1,106
Destruction of leaking blood vessels of retina using laser21$26,045$840
Exam of retinal blood vessels using a special camera after injection of a dye66$9,000$87
New patient complete exam of visual system69$7,776$113
Photocoagulation treatment to prevent detachment of retina14$6,604$440
Unclassified biologics57$6,392None
Destruction of growth of retina using a laser13$5,678$437
Removal of recurring cataract in lens capsule using a laser18$4,834$242
Photography of the retina35$2,309$66
New patient visit (45+ min)18$2,303$128
Injection, bevacizumab, 10 mg27$2,162None
Short return visit (20+ min)30$1,431$48
Exam of visual field with extended testing22$1,134$52
Imaging of optic nerve28$1,020$33

2013: 19 services

Original Medicare services billed in 2013
Injection, ranibizumab, 0.1 mg267$1,803,147None
Injection, aflibercept, 1 mg52$227,113None
Established patient problem focused exam of visual system666$153,140$67
Injection of drug into eye351$145,245$84
Imaging of retina1,058$113,031$36
Established patient complete exam of visual system906$100,556$91
Unclassified drugs12$35,497None
Removal of membrane of retina20$23,066$1,098
Destruction of leaking blood vessels of retina using laser23$22,507$776
New patient complete exam of visual system68$7,972$117
Injection, bevacizumab, 10 mg44$7,779None
Removal of recurring cataract in lens capsule using a laser30$7,763$250
Photocoagulation treatment to prevent detachment of retina16$7,464$439
Exam of retinal blood vessels using a special camera after injection of a dye54$7,055$89
Destruction of growth of retina using a laser12$6,120$437
Short return visit (20+ min)46$2,917$57
Exam of visual field with extended testing20$1,159$55
Photography of the retina15$847$56
Imaging of optic nerve19$748$36

Medicaid work

$7,549 in 2024

Medicaid paid $7,549 for 765 billed services this clinician did in 2024, up to 50 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Intravitreal injection of a pharmacologic agent (separate procedure)258$5,701
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina452$1,496
Short return visit (20+ min)12$211
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST15$100
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient28$41
Medicaid work by year
2024765550$7,549
20232,049655$17,653
20221,550441$10,549
2021720431$2,462
2020575531$1,825
2019678540$3,441
20181,814664$9,021
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Intravitreal injection of a pharmacologic agent (separate procedure)703$14,968
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina909$1,960
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient309$541
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST62$123
Short return visit (20+ min)26$60
Injection, bevacizumab, 10 mg40$0

2022

Largest Medicaid services in 2022
Intravitreal injection of a pharmacologic agent (separate procedure)477$8,775
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient312$997
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina748$777
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST13$0

2021

Largest Medicaid services in 2021
Intravitreal injection of a pharmacologic agent (separate procedure)158$951
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient155$948
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina392$439
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST15$124

2020

Largest Medicaid services in 2020
Intravitreal injection of a pharmacologic agent (separate procedure)119$732
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina282$588
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient140$471
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST15$35
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications19$0

2019

Largest Medicaid services in 2019
Intravitreal injection of a pharmacologic agent (separate procedure)156$1,962
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina300$902
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient166$543
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST12$35
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications44$0

2018

Largest Medicaid services in 2018
Intravitreal injection of a pharmacologic agent (separate procedure)547$4,661
Ranibizumab injection91$1,493
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina753$1,371
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient358$1,322
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST52$138
Short return visit (20+ min)13$37

Drugs they prescribed that Part D paid

$59,237

Pharmacies billed $59,237 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 789) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

443 generic and 346 brand-name prescriptions · $59,237 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Lumigan31$14,436$466
Prednisolone Acetate170$7,489$44
Brimonidine64$6,551$102
Alphagan P17$3,909$230
Cyclosporine16$2,694$168
See all 11 drugs
Every Part D drug this clinician prescribed
Lumigan31$14,436$466
Prednisolone Acetate170$7,489$44
Brimonidine64$6,551$102
Alphagan P17$3,909$230
Cyclosporine16$2,694$168
Latanoprost199$2,574$13
Timolol Maleate84$1,262$15
Ofloxacin45$693$15
Ketorolac Tromethamine28$535$19
Dorzolamide-Timolol22$485$22
Neomycin-Polymyxin-Dexameth17$370$22

Year by year

Part D prescribing by year
20247892290% (0)44%$59,237
20239392660% (0)49%$92,042
20221,0522790% (0)52%$98,173
20219812860% (0)48%$84,355
20201,1503150% (0)46%$112,002
20191,0172950% (0)43%$101,926
20181,292339None46%$126,960
20171,0062800% (0)45%$103,210
20167672160% (0)51%$87,236
2015724195None57%$87,648
2014671180None56%$71,118
20136291740% (0)60%$64,287

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 16 drugs

Part D drugs prescribed in 2023
Lumigan26$11,492$442
Restasis14$9,765$698
Alphagan P39$8,747$224
Prednisolone Acetate190$8,240$43
Brimonidine49$5,078$104
Prolensa12$4,870$406
Latanoprost218$4,618$21
Combigan14$2,807$201
Difluprednate13$2,167$167
Timolol Maleate115$2,077$18
Ofloxacin46$783$17
Ketorolac Tromethamine30$723$24
Dorzolamide-Timolol35$688$20
Neomycin-Polymyxin-Dexameth16$300$19
Polymyxin B Sul-Trimethoprim11$116$11
Prednisone12$73$6

2022: 15 drugs

Part D drugs prescribed in 2022
Lumigan27$11,492$426
Prednisolone Acetate233$10,402$45
Restasis12$9,957$830
Alphagan P42$8,926$213
Latanoprost283$5,895$21
Ilevro15$4,686$312
Prolensa11$4,363$397
Combigan15$3,037$202
Travoprost13$2,133$164
Timolol Maleate122$1,599$13
Ofloxacin86$1,250$15
Brimonidine19$1,215$64
Ketorolac Tromethamine31$1,106$36
Dorzolamide-Timolol19$750$39
Erythromycin13$155$12

2021: 14 drugs

Part D drugs prescribed in 2021
Restasis17$16,036$943
Lumigan24$9,455$394
Prednisolone Acetate174$8,897$51
Alphagan P36$7,350$204
Latanoprost300$6,282$21
Prolensa16$5,566$348
Travoprost16$3,577$224
Betimol12$1,818$152
Timolol Maleate120$1,412$12
Ofloxacin73$1,045$14
Olopatadine14$920$66
Dorzolamide-Timolol20$731$37
Neomycin-Polymyxin-Dexameth21$522$25
Polymyxin B Sul-Trimethoprim11$92$8

2020: 22 drugs

Part D drugs prescribed in 2020
Restasis19$17,410$916
Pazeo47$14,234$303
Lumigan27$9,489$351
Prednisolone Acetate185$8,839$48
Alphagan P44$8,105$184
Prolensa23$6,796$295
Latanoprost299$5,432$18
Travatan Z15$5,069$338
Durezol18$4,027$224
Travoprost12$2,859$238
Lotemax13$2,672$206
Betimol12$1,822$152
Olopatadine24$1,765$74
Bacitracin13$1,204$93
Brimonidine25$1,112$44
Timolol Maleate133$1,067$8
Ofloxacin66$1,040$16
Dorzolamide-Timolol15$872$58
Neomycin-Polymyxin-Dexameth29$807$28
Azelastine14$362$26
Erythromycin15$196$13
Polymyxin B Sul-Trimethoprim13$117$9

2019: 17 drugs

Part D drugs prescribed in 2019
Pazeo46$11,613$252
Travatan Z24$8,514$355
Durezol41$8,325$203
Lumigan18$7,113$395
Alphagan P29$6,129$211
Prolensa21$5,710$272
Latanoprost282$5,653$20
Prednisolone Acetate120$5,208$43
Lotemax23$4,706$205
Olopatadine30$3,923$131
Simbrinza16$2,555$160
Ofloxacin73$1,400$19
Dorzolamide-Timolol25$987$39
Timolol Maleate104$647$6
Azelastine18$645$36
Neomycin-Polymyxin-Dexameth18$475$26
Brimonidine13$379$29

2018: 18 drugs

Part D drugs prescribed in 2018
Durezol103$18,503$180
Lumigan23$9,621$418
Travatan Z26$9,259$356
Ilevro16$8,594$537
Prolensa30$8,022$267
Alphagan P45$7,627$169
Prednisolone Acetate137$6,318$46
Latanoprost332$6,201$19
Pazeo27$5,520$204
Lotemax25$5,237$209
Olopatadine52$4,788$92
Ofloxacin104$1,769$17
Bacitracin11$898$82
Neomycin-Polymyxin-Dexameth43$875$20
Timolol Maleate106$813$8
Dorzolamide-Timolol32$737$23
Brimonidine22$717$33
Dorzolamide18$344$19

2017: 19 drugs

Part D drugs prescribed in 2017
Travatan Z48$12,452$259
Lumigan28$10,713$383
Durezol61$10,072$165
Pataday35$8,476$242
Alphagan P53$7,848$148
Prednisolone Acetate91$4,482$49
Latanoprost247$4,177$17
Prolensa12$3,212$268
Pazeo14$3,137$224
Olopatadine29$2,849$98
Tobramycin-Dexamethasone15$1,934$129
Ofloxacin66$1,072$16
Brimonidine17$983$58
Neomycin-Polymyxin-Dexameth30$654$22
Timolol Maleate75$468$6
Dorzolamide-Timolol26$452$17
Diclofenac11$153$14
Polymyxin B Sul-Trimethoprim18$149$8
Dorzolamide13$144$11

2016: 14 drugs

Part D drugs prescribed in 2016
Lumigan48$15,378$320
Travatan Z36$9,841$273
Pataday39$8,668$222
Durezol53$8,208$155
Combigan41$6,076$148
Prednisolone Acetate68$4,947$73
Latanoprost170$3,122$18
Pazeo11$3,069$279
Alphagan P20$2,957$148
Timolol Maleate75$733$10
Olopatadine11$651$59
Neomycin-Polymyxin-Dexameth29$628$22
Dorzolamide-Timolol24$468$20
Polymyxin B Sul-Trimethoprim47$437$9

2015: 14 drugs

Part D drugs prescribed in 2015
Lumigan47$13,297$283
Restasis20$10,953$548
Pataday42$9,710$231
Prednisolone Acetate99$7,562$76
Travatan Z32$6,357$199
Azopt17$5,413$318
Combigan30$4,057$135
Alphagan P19$2,743$144
Latanoprost142$2,374$17
Tobramycin-Dexamethasone20$2,261$113
Timolol Maleate53$1,832$35
Durezol11$1,811$165
Dorzolamide-Timolol26$661$25
Polymyxin B Sul-Trimethoprim52$500$10

2014: 15 drugs

Part D drugs prescribed in 2014
Pataday59$10,770$183
Lumigan41$9,777$238
Restasis17$8,203$483
Travatan Z32$6,275$196
Prednisolone Acetate63$4,993$79
Combigan38$4,436$117
Azopt15$3,361$224
Bepreve11$2,181$198
Durezol16$2,025$127
Latanoprost119$1,880$16
Tobramycin-Dexamethasone20$1,852$93
Timolol Maleate59$1,071$18
Dorzolamide-Timolol35$1,041$30
Polymyxin B Sul-Trimethoprim25$253$10
Ofloxacin20$162$8

2013: 16 drugs

Part D drugs prescribed in 2013
Lumigan50$10,883$218
Pataday49$9,103$186
Restasis14$5,866$419
Travatan Z36$5,813$161
Patanol27$4,717$175
Azopt11$2,800$255
Prednisolone Acetate51$1,899$37
Latanoprost80$1,759$22
Combigan17$1,652$97
Vigamox11$1,427$130
Durezol11$1,427$130
Tobramycin-Dexamethasone13$1,253$96
Dorzolamide-Timolol34$1,098$32
Timolol Maleate48$910$19
Bacitracin11$631$57
Ofloxacin44$322$7

Money from drug and device companies

$788 in 2025

Industry payments by year
2025526None$788
2024737None$1,304
2023934$4,003$5,288
2022623None$658
2021718None$511
2020410None$190
2019950None$836

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Astellas Pharma USIzervay$348
15 payments
  • Meals for Izervay · 2025-12-22 · $23
  • Meals for Izervay · 2025-12-16 · $5
  • Meals for Izervay · 2025-11-18 · $18
  • Meals for Izervay · 2025-08-27 · $30
  • Meals for Izervay · 2025-08-12 · $21
  • Meals for Izervay · 2025-07-31 · $14
  • Meals for Izervay · 2025-06-25 · $27
  • Meals for Izervay · 2025-06-24 · $28
  • Meals for Izervay · 2025-05-28 · $25
  • Meals for Izervay · 2025-05-27 · $28
  • Meals for Izervay · 2025-04-22 · $16
  • Meals for Izervay · 2025-03-26 · $25
  • Meals for Izervay · 2025-02-19 · $30
  • Meals for Izervay · 2025-02-18 · $32
  • Meals for Izervay · 2025-01-08 · $26
Apellis PharmaceuticalsSyfovre$191
6 payments
  • Meals for Syfovre · 2025-09-18 · $23
  • Meals for Syfovre · 2025-09-17 · $5
  • Meals for Syfovre · 2025-06-20 · $25
  • Meals for Syfovre · 2025-06-13 · $2
  • Meals for Syfovre · 2025-05-14 · $125
  • Meals for Syfovre · 2025-02-12 · $12
Regeneron PharmaceuticalsEylea Hd$124
1 payment
  • Meals for Eylea Hd · 2025-04-10 · $124
AbbvieDurysta$98
3 payments
  • Meals for Durysta · 2025-04-26 · $35
  • Meals for Durysta · 2025-04-24 · $29
  • Meals for Durysta · 2025-03-19 · $34
Genentech USAVabysmo$26
1 payment
  • Meals for Vabysmo · 2025-01-23 · $26
See all 26 published payments
Every published payment
Astellas Pharma USMeals · 2025-12-22Izervay$23
Astellas Pharma USMeals · 2025-12-16Izervay$5
Astellas Pharma USMeals · 2025-11-18Izervay$18
Apellis PharmaceuticalsMeals · 2025-09-18Syfovre$23
Apellis PharmaceuticalsMeals · 2025-09-17Syfovre$5
Astellas Pharma USMeals · 2025-08-27Izervay$30
Astellas Pharma USMeals · 2025-08-12Izervay$21
Astellas Pharma USMeals · 2025-07-31Izervay$14
Astellas Pharma USMeals · 2025-06-25Izervay$27
Astellas Pharma USMeals · 2025-06-24Izervay$28
Apellis PharmaceuticalsMeals · 2025-06-20Syfovre$25
Apellis PharmaceuticalsMeals · 2025-06-13Syfovre$2
Astellas Pharma USMeals · 2025-05-28Izervay$25
Astellas Pharma USMeals · 2025-05-27Izervay$28
Apellis PharmaceuticalsMeals · 2025-05-14Syfovre$125
AbbvieMeals · 2025-04-26Durysta$35
AbbvieMeals · 2025-04-24Durysta$29
Astellas Pharma USMeals · 2025-04-22Izervay$16
Regeneron PharmaceuticalsMeals · 2025-04-10Eylea Hd$124
Astellas Pharma USMeals · 2025-03-26Izervay$25
AbbvieMeals · 2025-03-19Durysta$34
Astellas Pharma USMeals · 2025-02-19Izervay$30
Astellas Pharma USMeals · 2025-02-18Izervay$32
Apellis PharmaceuticalsMeals · 2025-02-12Syfovre$12
Genentech USAMeals · 2025-01-23Vabysmo$26
Astellas Pharma USMeals · 2025-01-08Izervay$26
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $1,304

Payments by company in 2024
Astellas Pharma USIzervay$498
11 payments
  • Meals for Izervay · 2024-12-18 · $25
  • Meals for Izervay · 2024-11-20 · $19
  • Meals for Izervay · 2024-10-30 · $19
  • Meals for Izervay · 2024-08-14 · $35
  • Meals for Izervay · 2024-07-11 · $22
  • Meals for Izervay · 2024-06-29 · $33
  • Meals for Izervay · 2024-06-14 · $22
  • Meals for Izervay · 2024-04-17 · $35
  • Meals for Izervay · 2024-04-03 · $35
  • Meals for Izervay · 2024-04-03 · $131
  • Meals for Izervay · 2024-01-09 · $122
Genentech USAVabysmo$346
15 payments
  • Meals for Vabysmo · 2024-11-26 · $26
  • Meals for Vabysmo · 2024-11-26 · $8
  • Meals for Vabysmo · 2024-09-26 · $2
  • Meals for Vabysmo · 2024-09-26 · $14
  • Meals for Vabysmo · 2024-09-26 · $9
  • Meals for Vabysmo · 2024-08-20 · $19
  • Meals for Vabysmo · 2024-06-26 · $26
  • Meals for Vabysmo · 2024-06-26 · $2
  • Meals for Vabysmo · 2024-05-10 · $5
  • Meals for Vabysmo · 2024-05-09 · $22
  • Meals for Vabysmo · 2024-05-09 · $122
  • Meals for Vabysmo · 2024-04-11 · $26
  • Meals for Vabysmo · 2024-03-21 · $20
  • Meals for Vabysmo · 2024-03-01 · $22
  • Meals for Vabysmo · 2024-02-29 · $22
Regeneron Healthcare SolutionsEylea Hd$266
3 payments
  • Meals for Eylea Hd · 2024-11-22 · $125
  • Meals for Eylea Hd · 2024-09-23 · $30
  • Meals for Eylea Hd · 2024-08-22 · $111
AbbvieDurysta$78
3 payments
  • Meals for Durysta · 2024-12-12 · $31
  • Meals for Ozurdex · 2024-05-07 · $17
  • Meals for Durysta · 2024-02-27 · $30
Apellis PharmaceuticalsSyfovre$59
3 payments
  • Meals for Syfovre · 2024-12-20 · $21
  • Meals for Syfovre · 2024-10-30 · $20
  • Meals for Syfovre · 2024-04-09 · $18
BiogenByooviz$29
1 payment
  • Meals for Byooviz · 2024-06-24 · $29
Dompe USOxervate$27
1 payment
  • Meals for Oxervate · 2024-07-23 · $27

2023: $5,288

Payments by company in 2023
Alexion PharmaceuticalsNone$4,003
2 payments
  • Consulting · 2023-10-27 · $240
  • Consulting · 2023-09-22 · $3,763
Mallinckrodt Hospital ProductsActhar$281
4 payments
  • Meals for Acthar · 2023-11-07 · $7
  • Meals for Acthar · 2023-10-10 · $20
  • Meals for Acthar · 2023-08-17 · $136
  • Meals for Acthar · 2023-03-22 · $117
Regeneron Healthcare SolutionsEylea$273
3 payments
  • Meals for Eylea Hd · 2023-10-11 · $122
  • Meals for Eylea · 2023-07-11 · $29
  • Meals for Eylea · 2023-02-23 · $122
Genentech USAVabysmo$236
11 payments
  • Meals for Vabysmo · 2023-12-04 · $16
  • Meals for Vabysmo · 2023-11-08 · $17
  • Meals for Vabysmo · 2023-10-12 · $9
  • Meals for Vabysmo · 2023-08-10 · $5
  • Meals for Vabysmo · 2023-08-10 · $122
  • Meals for Vabysmo · 2023-07-27 · $4
  • Meals for Vabysmo · 2023-06-13 · $5
  • Meals for Vabysmo · 2023-06-12 · $2
  • Meals for Vabysmo · 2023-05-03 · $26
  • Meals for Vabysmo · 2023-03-22 · $5
  • Meals for Vabysmo · 2023-03-22 · $25
Alimera SciencesIluvien$159
4 payments
  • Meals for Iluvien · 2023-11-16 · $95
  • Meals for Iluvien · 2023-10-25 · $23
  • Meals for Iluvien · 2023-09-19 · $23
  • Meals for Iluvien · 2023-04-18 · $18
Astellas Pharma USNone$126
4 payments
  • Meals · 2023-11-03 · $29
  • Meals · 2023-10-18 · $33
  • Meals · 2023-09-11 · $30
  • Meals · 2023-08-21 · $34
Regeneron PharmaceuticalsEylea$106
1 payment
  • Meals for Eylea · 2023-02-21 · $106
Apellis PharmaceuticalsSyfovre$87
4 payments
  • Meals for Syfovre · 2023-12-14 · $16
  • Meals for Syfovre · 2023-10-24 · $26
  • Meals for Syfovre · 2023-06-05 · $18
  • Meals for Syfovre · 2023-04-10 · $27
AbbVieOzurdex$17
1 payment
  • Meals for Ozurdex · 2023-12-13 · $17

2022: $658

Payments by company in 2022
Genentech USAVabysmo$187
13 payments
  • Meals for Vabysmo · 2022-11-05 · $23
  • Meals for Vabysmo · 2022-10-26 · $5
  • Meals for Vabysmo · 2022-10-12 · $4
  • Meals for Vabysmo · 2022-09-09 · $33
  • Meals · 2022-08-08 · $6
  • Meals for Vabysmo · 2022-07-29 · $4
  • Meals · 2022-07-28 · $10
  • Meals · 2022-07-28 · $8
  • Meals for Vabysmo · 2022-06-28 · $32
  • Meals for Vabysmo · 2022-06-01 · $3
  • Meals for Vabysmo · 2022-05-17 · $13
  • Meals for Susvimo · 2022-04-12 · $23
  • Meals for Vabysmo · 2022-03-01 · $25
Regeneron Healthcare SolutionsEylea$164
3 payments
  • Meals for Eylea · 2022-11-01 · $18
  • Meals for Eylea · 2022-09-15 · $123
  • Meals for Eylea · 2022-05-24 · $23
EyePoint Pharmaceuticals USYutiq$142
2 payments
  • Meals for Yutiq · 2022-06-30 · $125
  • Meals for Dexycu · 2022-05-02 · $17
Apellis PharmaceuticalsNone$133
3 payments
  • Meals · 2022-12-16 · $20
  • Meals · 2022-12-15 · $5
  • Meals · 2022-11-02 · $108
Alimera SciencesIluvien$16
1 payment
  • Meals for Iluvien · 2022-02-25 · $16
AbbvieOzurdex$15
1 payment
  • Meals for Ozurdex · 2022-06-21 · $15

2021: $511

Payments by company in 2021
Regeneron Healthcare SolutionsEylea$133
2 payments
  • Meals for Eylea · 2021-11-05 · $113
  • Meals for Eylea · 2021-04-24 · $20
Aerie PharmaceuticalsRhopressa$129
3 payments
  • Meals for Rhopressa · 2021-09-09 · $112
  • Meals for Rhopressa · 2021-08-31 · $5
  • Meals for Rocklatan · 2021-05-07 · $12
TissuetechProkera$100
6 payments
  • Meals for Prokera · 2021-10-04 · $13
  • Meals for Prokera · 2021-07-02 · $23
  • Meals for Prokera · 2021-05-13 · $13
  • Meals for Prokera · 2021-03-20 · $20
  • Meals for Prokera · 2021-02-01 · $19
  • Meals for Prokera · 2021-01-15 · $12
Genentech USALucentis$71
3 payments
  • Meals for Susvimo · 2021-11-09 · $21
  • Meals for Lucentis · 2021-03-16 · $25
  • Meals for Lucentis · 2021-01-14 · $25
AllerganOzurdex$40
2 payments
  • Meals for Ozurdex · 2021-11-16 · $24
  • Meals for Ozurdex · 2021-01-14 · $16
EyePoint Pharmaceuticals USDexycu$23
1 payment
  • Meals for Dexycu · 2021-11-11 · $23
Alimera SciencesIluvien$15
1 payment
  • Meals for Iluvien · 2021-01-06 · $15

2020: $190

Payments by company in 2020
TissueTechProkera$72
4 payments
  • Meals for Prokera · 2020-12-07 · $21
  • Meals for Prokera · 2020-11-19 · $21
  • Meals for Prokera · 2020-10-22 · $18
  • Meals for Prokera · 2020-10-22 · $13
AllerganOzurdex$50
3 payments
  • Meals for Ozurdex · 2020-11-19 · $16
  • Meals for Ozurdex · 2020-09-01 · $15
  • Meals for Ozurdex · 2020-01-13 · $20
Genentech USALucentis$49
2 payments
  • Meals for Lucentis · 2020-09-21 · $25
  • Meals for Lucentis · 2020-08-11 · $24
Alimera SciencesIluvien$19
1 payment
  • Meals for Iluvien · 2020-05-13 · $19

2019: $836

Payments by company in 2019
Novartis PharmaceuticalsBeovu$231
7 payments
  • Meals for Beovu · 2019-12-18 · $10
  • Meals for Beovu · 2019-12-12 · $109
  • Meals · 2019-04-29 · $20
  • Meals · 2019-04-29 · $17
  • Meals · 2019-04-29 · $21
  • Meals for Beovu · 2019-04-29 · $40
  • Meals for Beovu · 2019-04-29 · $13
Alimera SciencesIluvien$159
3 payments
  • Meals for Iluvien · 2019-08-13 · $19
  • Meals for Iluvien · 2019-05-20 · $26
  • Meals for Iluvien · 2019-04-18 · $115
Regeneron Healthcare SolutionsEylea$153
3 payments
  • Meals for Eylea · 2019-12-05 · $125
  • Meals for Eylea · 2019-11-06 · $3
  • Meals for Eylea · 2019-11-06 · $25
Regeneron PharmaceuticalsEylea$89
1 payment
  • Meals for Eylea · 2019-04-12 · $89
Genentech USALucentis$74
4 payments
  • Meals for Lucentis · 2019-12-13 · $14
  • Meals for Lucentis · 2019-07-03 · $20
  • Meals for Lucentis · 2019-04-05 · $16
  • Meals for Lucentis · 2019-01-24 · $25
Sun Pharmaceutical IndustriesCequa$67
1 payment
  • Meals for Cequa · 2019-10-30 · $67
Bausch & Lomb a division of Bausch Health USVisudyne$30
2 payments
  • Meals for Visudyne · 2019-07-29 · $19
  • Meals for Prolensa · 2019-05-13 · $11
AllerganOzurdex$19
1 payment
  • Meals for Ozurdex · 2019-10-16 · $19
TissueTechProkera$14
1 payment
  • Meals for Prokera · 2019-04-30 · $14

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Genentech, Inc. · Va2 Phiii Yosemite · 2020This clinician$22,023
Astellas Pharma Global Development · An Open-Label Extension (Ole) Phase 3 Trial To Assess the Safety of Intravitreal Administration of Avacincaptad Pegol (Complement C5 Inhibitor) in Patients With Geographic Atrophy Who Previously Completed Phase 3 Study Isee2008 (Gather2) · 2023Their institution$17,771
Genentech, Inc. · Va2 Phiii Yosemite · 2019This clinician$15,769
Genentech, Inc. · Faricimab Dme Long Term Extension Rhone X · 2022This clinician$15,288
Novartis Pharmaceuticals Corporation · A 12-Month, 2-Arm, Randomized, Double-Masked, Multicenter Phase III Study Assessing the Efficacy and Safety of Brolucizumab Vs. Aflibercept in Patients With Visual Impairment Due To Diabetic Macular Edema (Kingfisher) · 2020Their institution$15,275
Novartis Pharmaceuticals Corporation · A 12-Month, 2-Arm, Randomized, Double-Masked, Multicenter Phase III Study Assessing the Efficacy and Safety of Brolucizumab Vs. Aflibercept in Patients With Visual Impairment Due To Diabetic Macular Edema (Kingfisher) · 2019Their institution$12,130
Genentech, Inc. · Va2 Phiii Yosemite · 2021This clinician$11,741
Alexion Pharmaceuticals, Inc. · A Phase 2, Double Masked, Placebo Controlled, Dose Range Finding Study of Danicopan (Alxn2040) in Patients With Geographic Atrophy (Ga) Secondary To Age Related Macular Degeneration (Amd) · 2024This clinician$4,863
Genentech, Inc. · Faricimab Dme Long Term Extension Rhone X · 2023This clinician$4,608

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
89.9 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1447267505
Licence
CA G60951California G60951: Current · expires 2027-08-31
Trained
Creighton University School of Medicine, 1986 · 40 years ago
Group
Fogg Remington Eyecare Inc · Vision Care Center A Medical Group Inc
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00G609510
Taxonomy
Federal specialty code 207W00000X (207W00000X)
Mailing address
1360 E Herndon Avenue, Suite 301, Fresno, CA, 93720
NPI first listed
2006-08-02
NPI last updated
2007-07-08

This is when the NPI record was last certified, not a medical board exam.